Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy.

Authors: J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal: Lancet Date: 1968-09-14 Impact factor: 79.321

7. Long-term results of therapy in patients with chronic liver disease associated with hypergammaglobulinemia.

Authors: A R Page; R A Good; B Pollara
Journal: Am J Med Date: 1969-11 Impact factor: 4.965

8. [Correlation of the laparoscopic and histological findings in chronic hepatitis and liver cirrhosis].

Authors: I Vido; E Wildhirt
Journal: Dtsch Med Wochenschr Date: 1969-08-15 Impact factor: 0.628

9. Morphologic and etiologic diagnoses from hepatic biopsies without clinical data.

Authors: A H Baggenstoss
Journal: Medicine (Baltimore) Date: 1966-11 Impact factor: 1.889

9 in total

37 in total

1. Use of laparoscopy in liver disease.

Authors:
Journal: Br Med J Date: 1978-03-25

Review 2. Advances in the current treatment of autoimmune hepatitis.

Authors: Albert J Czaja
Journal: Dig Dis Sci Date: 2012-04-03 Impact factor: 3.199

3. Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes.

Authors: T Okuno; M Shindo; K Arai; M Matsumoto; M Takeda
Journal: Gastroenterol Jpn Date: 1990-02

Review 4. Needle biopsy of the liver. A critique of four currently available methods.

Authors: R R Babb; R J Jackman
Journal: West J Med Date: 1989-01

Review 5. Targeting Hepatic Fibrosis in Autoimmune Hepatitis.

Authors: Aldo J Montano-Loza; Ragesh B Thandassery; Albert J Czaja
Journal: Dig Dis Sci Date: 2016-07-19 Impact factor: 3.199

6. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C.

Authors: Tadashi Takeda; Takahiro Yasuda; Yuji Nakayama; Mika Nakaya; Megumi Kimura; Mariko Yamashita; Ayumi Sawada; Koji Abo; Setsuko Takeda; Hiroki Sakaguchi; Susumu Shiomi; Hitoshi Asai; Shuichi Seki
Journal: World J Gastroenterol Date: 2006-12-28 Impact factor: 5.742

Observer error and sampling variability tested in evaluation of hepatitis and cirrhosis by liver biopsy.

1. THE NATURAL HISTORY OF CIRRHOSIS. II. THE INFLUENCE OF ALCOHOL AND PRIOR HEPATITIS ON PATHOLOGY AND PROGNOSIS.

2. Needle biopsy of the liver in cirrhosis; diagnostic efficiency as determined by postmortem sampling.

3. Posthepatitic and alcoholic cirrhosis: clinicopathologic study of 43 cases of each.

4. Accuracy of sampling by needle biopsy in diffuse liver disease.

Review 5. Liver biopsy in the diagnosis of cirrhosis.

6. A classification of chronic hepatitis.

7. Long-term results of therapy in patients with chronic liver disease associated with hypergammaglobulinemia.

8. [Correlation of the laparoscopic and histological findings in chronic hepatitis and liver cirrhosis].

9. Morphologic and etiologic diagnoses from hepatic biopsies without clinical data.

1. Use of laparoscopy in liver disease.

Review 2. Advances in the current treatment of autoimmune hepatitis.

3. Histological improvement of chronic hepatitis B, and non-A, non-B with interferon treatment: application of a numerical scoring system for evaluating sequential morphologic changes.

Review 4. Needle biopsy of the liver. A critique of four currently available methods.

Review 5. Targeting Hepatic Fibrosis in Autoimmune Hepatitis.

6. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C.

7. Abnormal aminopyrine metabolism in patients with chronic hepatitis.

8. Noninvasive evaluation of hepatic fibrosis using frequency demodulation of ultrasound signals.

9. Liver disease and cell-mediated immunity in hepatitis-associated antigen (HAA) carriers.

10. Immunosuppressive treatment of chronic HBsAg-positive hepatitis in childhood.